Dexcom (DXCM) Common Equity (2010 - 2026)
Dexcom (DXCM) posted quarterly Common Equity of $2.6 billion for Q2 2026, up 1.88% year-over-year from $2.6 billion in Q2 2025, and down 11.35% quarter-over-quarter from $3.0 billion in Q1 2026.
Dexcom (DXCM) Common Equity (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Common Equity for 17 consecutive years, with $2.6 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Common Equity rose 1.88% year-over-year to $2.6 billion; the TTM figure through Jun 2026 stood at $2.6 billion (up 1.88% YoY), while the FY2025 annual figure was $2.7 billion, up 30.6% from the prior year.
- Common Equity declined to $2.6 billion in Q2 2026 per DXCM's latest filing, from $3.0 billion in the prior quarter.
- Across five years, Common Equity topped out at $3.0 billion in Q1 2026 and bottomed at $1.8 billion in Q3 2022.
- Historically, Common Equity has averaged $2.3 billion across 5 years, with a median of $2.3 billion in 2022.
- Annual changes were most pronounced in 2024 — Common Equity retreated 12.74% — and 2025, when it jumped 37.75%.
- Dexcom's Common Equity stood at $2.1 billion in 2022, then retreated by 2.96% to $2.1 billion in 2023, then advanced by 1.64% to $2.1 billion in 2024, then soared by 30.6% to $2.7 billion in 2025, then slipped by 4.54% to $2.6 billion in 2026.
- Business Quant data shows DXCM's Common Equity at $2.6 billion in Q2 2026, $3.0 billion in Q1 2026, and $2.7 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 12.63 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.62 Bn |
| Mar 31, 2026 | 2.96 Bn |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 2.57 Bn |
| Mar 31, 2025 | 2.27 Bn |
| Dec 31, 2024 | 2.10 Bn |
| Sep 30, 2024 | 1.98 Bn |
| Jun 30, 2024 | 2.43 Bn |
| Mar 31, 2024 | 2.25 Bn |
| Dec 31, 2023 | 2.07 Bn |
| Sep 30, 2023 | 2.27 Bn |
| Jun 30, 2023 | 2.10 Bn |
| Mar 31, 2023 | 2.23 Bn |
| Dec 31, 2022 | 2.13 Bn |
| Sep 30, 2022 | 1.82 Bn |
| Jun 30, 2022 | 2.26 Bn |
| Mar 31, 2022 | 2.19 Bn |
| Dec 31, 2021 | 2.04 Bn |
| Sep 30, 2021 | 1.91 Bn |